TOBRAMYCIN SOLUTION

TOBRAMYCIN SOLUTION was reported 12167 times

TOBRAMYCIN SOLUTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CRONOBACTER INFECTION 7 0.4667
1 INFECTIVE CORNEAL ULCER 8 0.2857
2 FLAVOBACTERIUM INFECTION 8 0.1818
3 CHOROIDITIS 64 0.1711
4 HEPATOSPLENOMEGALY NEONATAL 7 0.1667
5 INFECTIVE KERATITIS 11 0.1549
6 ACQUIRED FACTOR V DEFICIENCY 14 0.1273
7 ADMINISTRATION SITE SCAR 7 0.1129
8 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 610 0.1120
9 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 91 0.1019
10 CYSTIC FIBROSIS LUNG 12 0.0938
11 KERATITIS FUNGAL 17 0.0817
12 CYSTIC FIBROSIS 418 0.0754
13 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 30 0.0739
14 VENTILATION PERFUSION MISMATCH 20 0.0712
15 CYSTIC FIBROSIS RELATED DIABETES 10 0.0685
16 KERATITIS BACTERIAL 11 0.0675
17 TRACHEOSTOMY INFECTION 8 0.0656
18 NECROTISING SCLERITIS 9 0.0621
19 SLE ARTHRITIS 16 0.0563
20 INFECTIVE EXACERBATION OF BRONCHIECTASIS 16 0.0521
21 CORNEAL INFILTRATES 16 0.0510
22 CORNEAL THINNING 12 0.0467
23 ELBOW DEFORMITY 16 0.0462
24 VITAMIN K DEFICIENCY 18 0.0448
25 CORNEAL NEOVASCULARISATION 11 0.0445
26 OTOTOXICITY 81 0.0438
27 BLOOD IMMUNOGLOBULIN E DECREASED 7 0.0435
28 MYCOBACTERIUM CHELONAE INFECTION 32 0.0433
29 CORNEAL PERFORATION 26 0.0412
30 CORNEAL EPITHELIUM DEFECT 22 0.0379
31 FACTOR V INHIBITION 7 0.0361
32 CHOLANGITIS INFECTIVE 9 0.0338
33 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
34 TRICHOSPORON INFECTION 13 0.0321
35 TRACHEITIS 24 0.0315
36 BURKHOLDERIA CEPACIA COMPLEX INFECTION 9 0.0315
37 HYPOTONY OF EYE 13 0.0310
38 INCREASED VISCOSITY OF BRONCHIAL SECRETION 19 0.0298
39 PULMONARY FUNCTION TEST DECREASED 128 0.0292
40 PSEUDOMONAS INFECTION 249 0.0290
41 HYPOPYON 24 0.0290
42 RESPIRATORY TRACT INFECTION BACTERIAL 14 0.0281
43 RETINOPATHY OF PREMATURITY 15 0.0271
44 LUNG INFECTION PSEUDOMONAL 15 0.0269
45 PNEUMONIA PSEUDOMONAL 41 0.0267
46 DISTAL INTESTINAL OBSTRUCTION SYNDROME 9 0.0267
47 INFECTED DERMAL CYST 9 0.0249
48 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 13 0.0248
49 OVERLAP SYNDROME 16 0.0229
50 RESPIRATORY TRACT IRRITATION 23 0.0220
51 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 20 0.0216
52 MYCOBACTERIUM ABSCESSUS INFECTION 15 0.0210
53 TRACHEAL HAEMORRHAGE 7 0.0199
54 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 49 0.0198
55 CORNEAL OPACITY 26 0.0190
56 APLASTIC ANAEMIA 96 0.0184
57 PSEUDOMONAS TEST POSITIVE 15 0.0183
58 PSOAS ABSCESS 11 0.0177
59 HYPERBILIRUBINAEMIA NEONATAL 10 0.0172
60 THROMBOCYTOPENIA NEONATAL 7 0.0166
61 LUNG TRANSPLANT 57 0.0161
62 CORNEAL SCAR 8 0.0159
63 BRONCHIAL WALL THICKENING 11 0.0153
64 BACTERIAL DISEASE CARRIER 11 0.0151
65 RENAL TUBULAR INJURY 18 0.0148
66 ENDOPHTHALMITIS 87 0.0145
67 SPUTUM INCREASED 31 0.0143
68 ULCERATIVE KERATITIS 39 0.0142
69 RENAL TUBULAR NECROSIS 137 0.0140
70 LINEAR IGA DISEASE 23 0.0138
71 LUNG TRANSPLANT REJECTION 9 0.0136
72 CONJUNCTIVAL OEDEMA 14 0.0136
73 FORCED EXPIRATORY VOLUME DECREASED 38 0.0134
74 VESTIBULAR DISORDER 16 0.0131
75 CORNEAL EROSION 7 0.0130
76 SJS-TEN OVERLAP 9 0.0128
77 BRONCHIECTASIS 86 0.0128
78 CONJUNCTIVAL HYPERAEMIA 45 0.0126
79 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 13 0.0122
80 SERRATIA INFECTION 9 0.0121
81 SPUTUM ABNORMAL 8 0.0121
82 BRONCHITIS BACTERIAL 9 0.0119
83 FUSARIUM INFECTION 8 0.0114
84 SCEDOSPORIUM INFECTION 8 0.0113
85 DEVICE RELATED THROMBOSIS 11 0.0112
86 SPUTUM CULTURE POSITIVE 9 0.0111
87 BRONCHIAL SECRETION RETENTION 14 0.0110
88 ABDOMINAL COMPARTMENT SYNDROME 7 0.0110
89 ACINETOBACTER INFECTION 12 0.0110
90 NEPHROGENIC ANAEMIA 50 0.0108
91 CORNEAL OEDEMA 24 0.0107
92 REBOUND ACID HYPERSECRETION 32 0.0106
93 HYPERPARATHYROIDISM SECONDARY 26 0.0104
94 PAINFUL RESPIRATION 25 0.0104
95 STENOTROPHOMONAS INFECTION 14 0.0103
96 CHEST INJURY 21 0.0101
97 HEART TRANSPLANT 9 0.0099
98 PATHOGEN RESISTANCE 90 0.0099
99 OCULAR HYPERTENSION 19 0.0098
100 INCREASED BRONCHIAL SECRETION 25 0.0098
101 JAW FRACTURE 21 0.0097
102 DEAFNESS NEUROSENSORY 32 0.0097
103 RHONCHI 13 0.0094
104 NEPHROPATHY TOXIC 101 0.0090
105 KERATITIS 26 0.0085
106 PERIORBITAL PAIN 7 0.0083
107 CONTINUOUS HAEMODIAFILTRATION 8 0.0082
108 SINUS OPERATION 19 0.0080
109 RED MAN SYNDROME 7 0.0080
110 RASH MORBILLIFORM 22 0.0079
111 NASAL INFLAMMATION 8 0.0076
112 TOXIC ANTERIOR SEGMENT SYNDROME 8 0.0073
113 PNEUMONIA STAPHYLOCOCCAL 14 0.0071
114 PULMONARY FUNCTION TEST ABNORMAL 11 0.0071
115 BLOOD CULTURE POSITIVE 21 0.0070
116 DRUG RESISTANCE 180 0.0070
117 PLATELET TRANSFUSION 9 0.0070
118 INTRAOCULAR PRESSURE INCREASED 89 0.0070
119 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 16 0.0069
120 CANDIDA SEPSIS 6 0.0067
121 SPUTUM DISCOLOURED 62 0.0065
122 RUBBER SENSITIVITY 10 0.0065
123 CORNEAL DISORDER 14 0.0064
124 TOXIC EPIDERMAL NECROLYSIS 96 0.0063
125 LIP HAEMORRHAGE 8 0.0063
126 PSEUDOMEMBRANOUS COLITIS 14 0.0063
127 DRUG LEVEL INCREASED 102 0.0062
128 CONJUNCTIVITIS ALLERGIC 9 0.0061
129 METAMORPHOPSIA 11 0.0060
130 EYELID PAIN 12 0.0059
131 CHRONIC RESPIRATORY FAILURE 7 0.0058
132 ERYTHEMA OF EYELID 31 0.0057
133 LUNG ABSCESS 12 0.0057
134 INFUSION SITE DISCHARGE 10 0.0057
135 HAEMOPTYSIS 158 0.0057
136 RHINOVIRUS INFECTION 22 0.0056
137 PULMONARY HAEMORRHAGE 44 0.0056
138 TRACHEOSTOMY 8 0.0056
139 RESPIRATORY TRACT INFECTION VIRAL 13 0.0056
140 RESPIRATORY DISORDER NEONATAL 9 0.0055
141 ANGLE CLOSURE GLAUCOMA 14 0.0055
142 END STAGE RENAL DISEASE 100 0.0055
143 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 42 0.0054
144 RESPIRATORY SYMPTOM 15 0.0053
145 BLOODY DISCHARGE 6 0.0052
146 VASCULITIS 61 0.0052
147 INFUSION SITE BRUISING 11 0.0051
148 ASPERGILLUS INFECTION 33 0.0050
149 WALKING AID USER 32 0.0048
150 BLOOD UREA DECREASED 6 0.0048
151 CEREBELLAR INFARCTION 8 0.0047
152 UVEITIS 64 0.0047
153 ORAL CANDIDIASIS 62 0.0047
154 STAPHYLOCOCCAL SEPSIS 23 0.0047
155 EXOPHTHALMOS 10 0.0046
156 LUNG INFECTION 72 0.0046
157 FUNGAL PERITONITIS 7 0.0046
158 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
159 PSEUDOMONAL SEPSIS 8 0.0046
160 BRONCHIAL DISORDER 7 0.0045
161 STREPTOCOCCAL INFECTION 25 0.0045
162 ACUTE KIDNEY INJURY 685 0.0045
163 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0045
164 TOTAL LUNG CAPACITY DECREASED 7 0.0044
165 SOCIAL PROBLEM 18 0.0043
166 CENTRAL VENOUS CATHETERISATION 13 0.0043
167 HEPATOSPLENOMEGALY 11 0.0043
168 EYE PAIN 238 0.0042
169 MECHANICAL VENTILATION 8 0.0042
170 MULTIPLE-DRUG RESISTANCE 13 0.0042
171 PNEUMONIA BACTERIAL 38 0.0041
172 DEAFNESS BILATERAL 7 0.0041
173 CLOSTRIDIUM TEST POSITIVE 9 0.0041
174 GASTROINTESTINAL HYPOMOTILITY 9 0.0040
175 SYSTEMIC CANDIDA 10 0.0040
176 INFUSION SITE HAEMORRHAGE 13 0.0039
177 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34 0.0039
178 EYELID DISORDER 9 0.0039
179 PNEUMOMEDIASTINUM 7 0.0039
180 PRODUCTIVE COUGH 184 0.0039
181 CHRONIC KIDNEY DISEASE 290 0.0038
182 AORTIC ANEURYSM 29 0.0038
183 PNEUMONIA KLEBSIELLA 7 0.0038
184 ADENOVIRUS INFECTION 11 0.0038
185 PNEUMOTHORAX 60 0.0038
186 PUPILLARY REFLEX IMPAIRED 7 0.0038
187 VITRITIS 7 0.0038
188 STEATORRHOEA 10 0.0037
189 CREPITATIONS 11 0.0037
190 HAEMODIALYSIS 31 0.0037
191 LUNG DISORDER 179 0.0036
192 BRONCHOSPASM 52 0.0036
193 GASTROINTESTINAL TUBE INSERTION 9 0.0036
194 DIASTOLIC DYSFUNCTION 11 0.0036
195 CREATININE RENAL CLEARANCE DECREASED 14 0.0035
196 BLOOD CHLORIDE INCREASED 6 0.0035
197 TUBULOINTERSTITIAL NEPHRITIS 65 0.0035
198 HYPERTRANSAMINASAEMIA 24 0.0034
199 APHONIA 48 0.0034
200 BACTERIAL INFECTION 64 0.0034
201 PROTEINURIA 65 0.0034
202 ARTHRITIS BACTERIAL 14 0.0034
203 BACTERIAL SEPSIS 11 0.0034
204 EYE INFECTION 38 0.0034
205 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 57 0.0034
206 SWELLING OF EYELID 21 0.0033
207 VISUAL ACUITY REDUCED 111 0.0033
208 WEIGHT ABNORMAL 8 0.0033
209 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
210 EMERGENCY CARE 10 0.0033
211 PNEUMONIA FUNGAL 13 0.0033
212 PERIORBITAL OEDEMA 17 0.0033
213 RALES 19 0.0033
214 EYE OEDEMA 8 0.0033
215 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
216 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
217 EYELID IRRITATION 8 0.0032
218 EYELID OEDEMA 37 0.0032
219 FOREIGN BODY SENSATION IN EYES 20 0.0031
220 PHOTOPHOBIA 59 0.0031
221 CONJUNCTIVITIS 58 0.0031
222 OCULAR DISCOMFORT 35 0.0031
223 ATELECTASIS 30 0.0031
224 ENTEROCOCCAL INFECTION 15 0.0031
225 COMPUTERISED TOMOGRAM ABNORMAL 7 0.0031
226 RENAL FAILURE ACUTE 130 0.0031
227 OXYGEN SATURATION DECREASED 172 0.0031
228 GRAFT VERSUS HOST DISEASE 22 0.0031
229 STAPHYLOCOCCAL INFECTION 100 0.0030
230 INFECTION 438 0.0030
231 PATENT DUCTUS ARTERIOSUS 12 0.0030
232 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
233 CHRONIC SINUSITIS 11 0.0029
234 OXYGEN CONSUMPTION INCREASED 7 0.0029
235 HOSPITALISATION 450 0.0029
236 PORTAL HYPERTENSION 9 0.0029
237 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 75 0.0029
238 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82 0.0029
239 LYMPHADENITIS 7 0.0029
240 CONJUNCTIVAL HAEMORRHAGE 11 0.0029
241 SEPTIC SHOCK 125 0.0029
242 INFUSION SITE SWELLING 18 0.0029
243 IRIDOCYCLITIS 9 0.0028
244 DISEASE COMPLICATION 13 0.0028
245 PERIORBITAL SWELLING 16 0.0028
246 PULMONARY CONGESTION 37 0.0028
247 ENTEROCOLITIS 16 0.0028
248 BRAIN ABSCESS 7 0.0028
249 HAEMOTHORAX 8 0.0028
250 HEPATOMEGALY 27 0.0027
251 ABDOMINAL INFECTION 7 0.0027
252 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
253 SECRETION DISCHARGE 34 0.0027
254 RESPIRATORY DISORDER 81 0.0027
255 MUCORMYCOSIS 7 0.0027
256 INFUSION SITE REACTION 8 0.0027
257 HYPERCAPNIA 8 0.0027
258 RESPIRATION ABNORMAL 18 0.0026
259 LUNG INFILTRATION 23 0.0026
260 MULTI-ORGAN FAILURE 45 0.0026
261 FIBROSIS 8 0.0026
262 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
263 EYELIDS PRURITUS 8 0.0026
264 WHEEZING 152 0.0026
265 VITREOUS HAEMORRHAGE 7 0.0025
266 SERUM SICKNESS 7 0.0025
267 PNEUMONIA VIRAL 8 0.0025
268 OSTEOPENIA 38 0.0025
269 LUNG CONSOLIDATION 7 0.0025
270 C-REACTIVE PROTEIN ABNORMAL 16 0.0025
271 BRONCHITIS CHRONIC 6 0.0025
272 NASAL POLYPS 12 0.0024
273 BREATH SOUNDS ABNORMAL 12 0.0024
274 BLOOD IMMUNOGLOBULIN G DECREASED 6 0.0024
275 INFLAMMATORY MARKER INCREASED 12 0.0024
276 ESCHERICHIA SEPSIS 7 0.0024
277 HYPERNATRAEMIA 12 0.0024
278 RENAL FAILURE 319 0.0024
279 GASTROINTESTINAL NECROSIS 7 0.0024
280 RETINAL DETACHMENT 22 0.0024
281 RESPIRATORY DISTRESS 66 0.0024
282 ACUTE RESPIRATORY FAILURE 46 0.0024
283 PROTEIN TOTAL DECREASED 9 0.0024
284 HYPOXIA 84 0.0024
285 LACRIMATION INCREASED 72 0.0024
286 KLEBSIELLA INFECTION 12 0.0024
287 CANDIDA INFECTION 40 0.0024
288 PARANASAL SINUS HYPERSECRETION 9 0.0024
289 SMALL INTESTINAL OBSTRUCTION 29 0.0024
290 PNEUMONIA 759 0.0023
291 RESPIRATORY TRACT INFECTION 61 0.0023
292 OBSTRUCTIVE AIRWAYS DISORDER 26 0.0023
293 PUSTULAR PSORIASIS 8 0.0023
294 RENAL INJURY 69 0.0023
295 DEAFNESS 60 0.0023
296 DIALYSIS 32 0.0023
297 OCULAR HYPERAEMIA 107 0.0023
298 TRANSPLANT REJECTION 18 0.0022
299 BLEPHARITIS 9 0.0022
300 HAEMOLYTIC ANAEMIA 20 0.0022
301 HYPOVOLAEMIA 13 0.0022
302 HYPERBILIRUBINAEMIA 23 0.0022
303 ORGANISING PNEUMONIA 11 0.0022
304 VASCULAR DEVICE INFECTION 10 0.0022
305 INTESTINAL ISCHAEMIA 12 0.0022
306 MUCOSAL INFLAMMATION 57 0.0022
307 PROTHROMBIN TIME PROLONGED 13 0.0022
308 PATHOLOGICAL FRACTURE 11 0.0022
309 RESPIRATORY FAILURE 157 0.0022
310 EYE PRURITUS 72 0.0021
311 UMBILICAL HERNIA 10 0.0021
312 PERIPHERAL VASCULAR DISORDER 11 0.0021
313 FEBRILE BONE MARROW APLASIA 9 0.0021
314 EYE DISCHARGE 22 0.0021
315 PULMONARY HYPERTENSION 44 0.0021
316 EOSINOPHILIA 37 0.0021
317 BACTERAEMIA 25 0.0021
318 TRANSFUSION 22 0.0021
319 INSURANCE ISSUE 32 0.0021
320 HORDEOLUM 9 0.0021
321 EJECTION FRACTION DECREASED 32 0.0021
322 TINNITUS 94 0.0020
323 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 98 0.0020
324 RESPIRATORY RATE INCREASED 18 0.0020
325 LOW BIRTH WEIGHT BABY 16 0.0020
326 DERMATITIS EXFOLIATIVE 10 0.0020
327 CANDIDIASIS 8 0.0020
328 LEUKOCYTOSIS 36 0.0020
329 COAGULOPATHY 33 0.0020
330 ANURIA 17 0.0020
331 IMMUNE THROMBOCYTOPENIA 9 0.0020
332 APPENDICECTOMY 7 0.0020
333 STEVENS-JOHNSON SYNDROME 43 0.0019
334 OLIGURIA 12 0.0019
335 RASH MACULO-PAPULAR 43 0.0019
336 SINUS DISORDER 38 0.0019
337 EXERCISE TOLERANCE DECREASED 11 0.0019
338 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
339 EYE SWELLING 71 0.0019
340 VIRAL INFECTION 63 0.0019
341 BLOOD ALBUMIN DECREASED 15 0.0019
342 NYSTAGMUS 10 0.0019
343 RENAL IMPAIRMENT 158 0.0019
344 LUNG NEOPLASM 8 0.0019
345 HEPATIC NECROSIS 7 0.0019
346 HEPATIC LESION 8 0.0018
347 ACUTE RESPIRATORY DISTRESS SYNDROME 32 0.0018
348 ANEURYSM 9 0.0018
349 ANXIETY DISORDER 6 0.0018
350 MALNUTRITION 20 0.0018
351 RESPIRATORY ACIDOSIS 7 0.0018
352 NEUROTOXICITY 31 0.0018
353 PERONEAL NERVE PALSY 10 0.0018
354 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
355 ASTHMA 193 0.0017
356 HAEMODYNAMIC INSTABILITY 13 0.0017
357 EYE IRRITATION 98 0.0017
358 ESCHERICHIA INFECTION 14 0.0017
359 ACIDOSIS 13 0.0017
360 SEASONAL ALLERGY 24 0.0017
361 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
362 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
363 BONE LESION 6 0.0017
364 PULMONARY THROMBOSIS 18 0.0016
365 ASPIRATION 18 0.0016
366 BLOOD PRESSURE SYSTOLIC INCREASED 32 0.0016
367 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
368 ENCEPHALOPATHY 40 0.0016
369 HYPOACUSIS 70 0.0016
370 BLOOD CREATININE INCREASED 106 0.0016
371 POST PROCEDURAL COMPLICATION 31 0.0016
372 HAEMATOCRIT DECREASED 32 0.0016
373 NEPHROLITHIASIS 74 0.0016
374 BLOOD UREA INCREASED 27 0.0016
375 NEPHROPATHY 15 0.0016
376 MACULAR OEDEMA 9 0.0016
377 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
378 SEPSIS 178 0.0016
379 COUGH 447 0.0016
380 DYSPHONIA 93 0.0016
381 DERMATITIS CONTACT 18 0.0016
382 ANHEDONIA 41 0.0016
383 CARDIOMEGALY 19 0.0015
384 HERPES SIMPLEX 10 0.0015
385 PETECHIAE 16 0.0015
386 MULTIPLE ALLERGIES 12 0.0015
387 POLYARTHRITIS 8 0.0015
388 UNRESPONSIVE TO STIMULI 39 0.0015
389 ARTHRITIS INFECTIVE 7 0.0015
390 FOOD POISONING 8 0.0015
391 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
392 MYASTHENIA GRAVIS 12 0.0015
393 SINUS CONGESTION 20 0.0015
394 CARDIAC TAMPONADE 7 0.0015
395 DECUBITUS ULCER 12 0.0015
396 INFLAMMATION 76 0.0015
397 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
398 HYDROCEPHALUS 8 0.0015
399 PANCREATITIS ACUTE 33 0.0015
400 ABNORMAL FAECES 12 0.0015
401 CONDITION AGGRAVATED 442 0.0015
402 RESPIRATORY TRACT CONGESTION 23 0.0014
403 FEBRILE NEUTROPENIA 96 0.0014
404 INFUSION SITE EXTRAVASATION 9 0.0014
405 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 75 0.0014
406 RENAL FAILURE CHRONIC 11 0.0014
407 ABSCESS LIMB 6 0.0014
408 BLOOD BILIRUBIN INCREASED 38 0.0014
409 BRONCHITIS 104 0.0014
410 TREATMENT FAILURE 116 0.0014
411 TACHYPNOEA 19 0.0014
412 INFLUENZA 155 0.0014
413 URINE OUTPUT DECREASED 12 0.0014
414 SPLENOMEGALY 16 0.0014
415 RHINITIS 11 0.0014
416 MENINGITIS 9 0.0013
417 PLEURAL EFFUSION 82 0.0013
418 SINUSITIS 138 0.0013
419 BRAIN OEDEMA 17 0.0013
420 PERICARDIAL EFFUSION 31 0.0013
421 CHEST DISCOMFORT 137 0.0013
422 HEARING IMPAIRED 8 0.0013
423 CARDIOGENIC SHOCK 19 0.0013
424 ECONOMIC PROBLEM 20 0.0013
425 EYE MOVEMENT DISORDER 9 0.0013
426 ILL-DEFINED DISORDER 79 0.0013
427 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
428 ELECTROLYTE IMBALANCE 15 0.0013
429 AUTISM SPECTRUM DISORDER 7 0.0013
430 PANCYTOPENIA 71 0.0013
431 SINUS TACHYCARDIA 18 0.0013
432 QUALITY OF LIFE DECREASED 17 0.0013
433 EYE INFLAMMATION 12 0.0013
434 LOWER RESPIRATORY TRACT INFECTION 57 0.0013
435 SPINAL OSTEOARTHRITIS 11 0.0013
436 APHAGIA 6 0.0012
437 CHOLECYSTITIS ACUTE 7 0.0012
438 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
439 MOUTH HAEMORRHAGE 9 0.0012
440 VENTRICULAR SEPTAL DEFECT 7 0.0012
441 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
442 OSTEOMYELITIS 22 0.0012
443 PHARYNGITIS 15 0.0012
444 ABDOMINAL TENDERNESS 6 0.0012
445 PYREXIA 415 0.0012
446 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
447 POST-TRAUMATIC STRESS DISORDER 8 0.0012
448 ASCITES 35 0.0012
449 ALANINE AMINOTRANSFERASE INCREASED 73 0.0012
450 EYE DISORDER 39 0.0012
451 INFUSION SITE ERYTHEMA 10 0.0012
452 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
453 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
454 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
455 DYSPNOEA 667 0.0012
456 DRUG TOXICITY 16 0.0012
457 ODYNOPHAGIA 7 0.0012
458 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
459 BONE DISORDER 21 0.0012
460 MENTAL STATUS CHANGES 32 0.0012
461 LARGE INTESTINE PERFORATION 8 0.0012
462 WEIGHT FLUCTUATION 12 0.0011
463 PRODUCT USE IN UNAPPROVED INDICATION 282 0.0011
464 PAPULE 8 0.0011
465 SCOLIOSIS 7 0.0011
466 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62 0.0011
467 DRUG INTOLERANCE 109 0.0011
468 ABSCESS 18 0.0011
469 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
470 EAR INFECTION 30 0.0011
471 THROMBOCYTOPENIA 126 0.0011
472 BRUXISM 6 0.0011
473 LIGAMENT SPRAIN 11 0.0011
474 DECREASED ACTIVITY 12 0.0011
475 HYPOCALCAEMIA 21 0.0011
476 GASTROENTERITIS VIRAL 20 0.0011
477 ATAXIA 13 0.0011
478 SHOCK 25 0.0011
479 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
480 CARDIOMYOPATHY 16 0.0011
481 HYPERSOMNIA 31 0.0011
482 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
483 PRODUCT DISTRIBUTION ISSUE 10 0.0011
484 THERAPY INTERRUPTED 77 0.0011
485 HEPATIC STEATOSIS 20 0.0011
486 LIVER FUNCTION TEST INCREASED 23 0.0011
487 PRESYNCOPE 26 0.0011
488 THERAPY NON-RESPONDER 48 0.0011
489 PNEUMONITIS 29 0.0011
490 GALLBLADDER DISORDER 19 0.0011
491 DYSPNOEA EXERTIONAL 40 0.0011
492 RESPIRATORY DEPRESSION 13 0.0011
493 MITRAL VALVE INCOMPETENCE 12 0.0011
494 TENDERNESS 11 0.0011
495 HYPERKALAEMIA 37 0.0011
496 CELLULITIS 53 0.0011
497 GENERALISED OEDEMA 13 0.0010
498 FUNGAL INFECTION 35 0.0010
499 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
500 SCRATCH 11 0.0010
501 PSYCHOLOGICAL TRAUMA 9 0.0010
502 PULMONARY FIBROSIS 20 0.0010
503 PNEUMONIA ASPIRATION 26 0.0010
504 TUMOUR LYSIS SYNDROME 9 0.0010
505 DRUG INTERACTION 162 0.0010
506 RIB FRACTURE 21 0.0010
507 CYANOSIS 16 0.0010
508 NEUROPATHY PERIPHERAL 96 0.0010
509 RENAL CYST 8 0.0010
510 PULMONARY MASS 15 0.0010
511 OESOPHAGITIS 11 0.0010
512 GINGIVAL PAIN 8 0.0010
513 RASH ERYTHEMATOUS 48 0.0010
514 GASTROINTESTINAL INFECTION 9 0.0010
515 MYOSITIS 9 0.0010
516 FOOT FRACTURE 19 0.0010
517 TOOTH FRACTURE 11 0.0010
518 HYPOKALAEMIA 46 0.0010
519 CHOLESTASIS 19 0.0010
520 MUSCULOSKELETAL DISCOMFORT 17 0.0010
521 BLOOD POTASSIUM INCREASED 16 0.0010
522 RETINAL HAEMORRHAGE 7 0.0010
523 SHOCK HAEMORRHAGIC 8 0.0010
524 BLOOD CALCIUM DECREASED 11 0.0010
525 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0010
526 IMPAIRED QUALITY OF LIFE 14 0.0010
527 HYPERCALCAEMIA 12 0.0010
528 FEELING COLD 27 0.0010
529 ILEUS 12 0.0010
530 BLINDNESS 39 0.0010
531 LETHARGY 55 0.0010
532 DELIRIUM 33 0.0009
533 OSTEOPOROSIS 39 0.0009
534 SKIN LESION 26 0.0009
535 MUSCLE ATROPHY 12 0.0009
536 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
537 HEPATIC ENZYME INCREASED 64 0.0009
538 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
539 SNEEZING 21 0.0009
540 VITAMIN D DECREASED 8 0.0009
541 NEUTROPENIA 127 0.0009
542 HYPOMAGNESAEMIA 13 0.0009
543 COVID-19 PNEUMONIA 11 0.0009
544 HEART RATE IRREGULAR 21 0.0009
545 HAEMORRHOIDS 18 0.0009
546 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
547 BODY TEMPERATURE DECREASED 9 0.0009
548 DEVICE RELATED INFECTION 14 0.0009
549 HYPOTENSION 182 0.0009
550 FOOD ALLERGY 7 0.0009
551 CATARACT 54 0.0009
552 BLOOD PRESSURE ABNORMAL 18 0.0009
553 DENTAL CARIES 10 0.0009
554 CARDIAC FAILURE ACUTE 6 0.0009
555 TACHYCARDIA 80 0.0009
556 SALIVARY HYPERSECRETION 9 0.0009
557 LEUKOPENIA 45 0.0009
558 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
559 EYELID PTOSIS 9 0.0009
560 AGEUSIA 22 0.0009
561 TRICUSPID VALVE INCOMPETENCE 7 0.0009
562 HYPERSENSITIVITY 163 0.0009
563 WEIGHT DECREASED 245 0.0009
564 METABOLIC ACIDOSIS 28 0.0009
565 INTESTINAL OBSTRUCTION 33 0.0009
566 LOCALISED INFECTION 21 0.0009
567 VENTRICULAR EXTRASYSTOLES 9 0.0009
568 OFF LABEL USE 755 0.0009
569 TOXICITY TO VARIOUS AGENTS 145 0.0009
570 MASS 12 0.0009
571 TRANSAMINASES INCREASED 19 0.0009
572 INFUSION SITE PAIN 11 0.0009
573 SLEEP DISORDER 60 0.0008
574 HIATUS HERNIA 11 0.0008
575 BLOOD SODIUM DECREASED 16 0.0008
576 PAIN IN JAW 24 0.0008
577 GASTROOESOPHAGEAL REFLUX DISEASE 68 0.0008
578 CHEST PAIN 156 0.0008
579 MYOCLONUS 10 0.0008
580 NASAL CONGESTION 49 0.0008
581 ANOSMIA 12 0.0008
582 HEART RATE DECREASED 29 0.0008
583 FLUID OVERLOAD 12 0.0008
584 HYPOPHAGIA 21 0.0008
585 OROPHARYNGEAL PAIN 76 0.0008
586 KIDNEY INFECTION 16 0.0008
587 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58 0.0008
588 ANAPHYLACTIC REACTION 45 0.0008
589 CARDIAC OPERATION 7 0.0008
590 BLOOD MAGNESIUM DECREASED 7 0.0008
591 INTENTIONAL DOSE OMISSION 23 0.0008
592 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
593 SEIZURE 93 0.0008
594 JOINT SWELLING 97 0.0008
595 SURGERY 47 0.0008
596 DRY EYE 40 0.0008
597 VISION BLURRED 110 0.0008
598 PREMATURE BABY 24 0.0008
599 PRODUCT DOSE OMISSION 52 0.0008
600 IMMUNOSUPPRESSION 7 0.0008
601 EMPHYSEMA 8 0.0008
602 ORAL DISCOMFORT 11 0.0008
603 RECTAL HAEMORRHAGE 34 0.0008
604 LYMPHADENOPATHY 28 0.0008
605 GASTRIC ULCER 15 0.0008
606 NECK PAIN 44 0.0008
607 VENTRICULAR TACHYCARDIA 13 0.0008
608 PULMONARY OEDEMA 35 0.0008
609 ATRIAL FIBRILLATION 76 0.0008
610 THERAPY CESSATION 40 0.0008
611 OROPHARYNGEAL DISCOMFORT 7 0.0008
612 RHINORRHOEA 50 0.0008
613 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
614 GASTROINTESTINAL DISORDER 69 0.0008
615 INJURY 54 0.0008
616 PRODUCT USE ISSUE 144 0.0008
617 BLOOD POTASSIUM DECREASED 23 0.0008
618 HAEMATURIA 26 0.0008
619 MENTAL DISORDER 33 0.0008
620 LIVER FUNCTION TEST ABNORMAL 22 0.0008
621 GENERAL PHYSICAL HEALTH DETERIORATION 87 0.0008
622 TREATMENT NONCOMPLIANCE 41 0.0007
623 NIGHT SWEATS 24 0.0007
624 MUSCULOSKELETAL PAIN 39 0.0007
625 SQUAMOUS CELL CARCINOMA 7 0.0007
626 FEAR 20 0.0007
627 BURSITIS 9 0.0007
628 NEURALGIA 18 0.0007
629 CARDIAC ARREST 61 0.0007
630 IMMUNODEFICIENCY 11 0.0007
631 EPISTAXIS 55 0.0007
632 DRUG ERUPTION 13 0.0007
633 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
634 ILLNESS 75 0.0007
635 HAEMOGLOBIN DECREASED 74 0.0007
636 VENTRICULAR FIBRILLATION 8 0.0007
637 COVID-19 126 0.0007
638 VITAMIN D DEFICIENCY 7 0.0007
639 CHILLS 84 0.0007
640 MOUTH ULCERATION 15 0.0007
641 THERAPY CHANGE 7 0.0007
642 FISTULA 8 0.0007
643 FACE OEDEMA 12 0.0007
644 TENDONITIS 11 0.0007
645 STATUS EPILEPTICUS 8 0.0007
646 LYMPHOPENIA 10 0.0007
647 HEART RATE INCREASED 70 0.0007
648 UNEVALUABLE EVENT 53 0.0007
649 LIMB INJURY 19 0.0007
650 CEREBRAL INFARCTION 17 0.0007
651 GASTRIC HAEMORRHAGE 8 0.0007
652 CARDIAC MURMUR 6 0.0007
653 PRODUCT ADMINISTRATION ERROR 14 0.0007
654 HYPONATRAEMIA 39 0.0007
655 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
656 BONE MARROW FAILURE 14 0.0007
657 DRY THROAT 7 0.0007
658 HYPERGLYCAEMIA 25 0.0007
659 DEVICE USE ISSUE 12 0.0007
660 COLITIS 26 0.0007
661 MUSCULOSKELETAL STIFFNESS 60 0.0007
662 MEDICATION ERROR 38 0.0007
663 NASOPHARYNGITIS 126 0.0007
664 CHOLECYSTITIS 8 0.0007
665 IMPAIRED HEALING 22 0.0007
666 POLYNEUROPATHY 8 0.0007
667 THROAT TIGHTNESS 18 0.0007
668 PANCREATITIS 35 0.0007
669 CYTOMEGALOVIRUS INFECTION 11 0.0007
670 VISUAL IMPAIRMENT 82 0.0007
671 ADRENAL INSUFFICIENCY 8 0.0007
672 BODY HEIGHT DECREASED 7 0.0007
673 BACK PAIN 152 0.0007
674 CYTOPENIA 8 0.0007
675 DEHYDRATION 87 0.0007
676 MATERNAL EXPOSURE DURING PREGNANCY 58 0.0007
677 BALANCE DISORDER 56 0.0006
678 PHARYNGITIS STREPTOCOCCAL 7 0.0006
679 URINARY TRACT INFECTION 110 0.0006
680 BACK INJURY 7 0.0006
681 SCAR 11 0.0006
682 PULMONARY EMBOLISM 61 0.0006
683 CHOLELITHIASIS 21 0.0006
684 WOUND INFECTION 7 0.0006
685 BRAIN FOG 10 0.0006
686 HEPATOCELLULAR INJURY 9 0.0006
687 PRODUCT USE COMPLAINT 10 0.0006
688 HEPATOTOXICITY 14 0.0006
689 ACCIDENTAL OVERDOSE 23 0.0006
690 PREMATURE DELIVERY 10 0.0006
691 INTENTIONAL PRODUCT USE ISSUE 55 0.0006
692 PARAESTHESIA ORAL 9 0.0006
693 RASH GENERALISED 16 0.0006
694 HEPATIC FUNCTION ABNORMAL 23 0.0006
695 AUTOIMMUNE DISORDER 6 0.0006
696 SWELLING FACE 40 0.0006
697 MALAISE 269 0.0006
698 PRODUCT DOSE OMISSION ISSUE 180 0.0006
699 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
700 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 11 0.0006
701 BRAIN INJURY 6 0.0006
702 RASH 258 0.0006
703 HAEMATEMESIS 15 0.0006
704 OEDEMA 32 0.0006
705 DISEASE RECURRENCE 28 0.0006
706 PALLOR 16 0.0006
707 LACTIC ACIDOSIS 19 0.0006
708 ACCIDENT 7 0.0006
709 GINGIVAL BLEEDING 8 0.0006
710 HYPERLIPIDAEMIA 7 0.0006
711 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
712 DECREASED APPETITE 135 0.0006
713 VOMITING 273 0.0006
714 RENAL DISORDER 27 0.0006
715 DIPLOPIA 15 0.0006
716 NOCTURIA 7 0.0006
717 CHROMATURIA 13 0.0006
718 VERTIGO 35 0.0006
719 CARDIO-RESPIRATORY ARREST 24 0.0006
720 SEROTONIN SYNDROME 11 0.0006
721 LIP SWELLING 19 0.0006
722 TENDON RUPTURE 7 0.0006
723 OSTEONECROSIS OF JAW 14 0.0006
724 OBESITY 9 0.0006
725 LIVER DISORDER 25 0.0006
726 RETCHING 12 0.0006
727 CONSTIPATION 122 0.0006
728 DIARRHOEA 360 0.0006
729 THROAT IRRITATION 25 0.0006
730 BLISTER 31 0.0006
731 DEATH 475 0.0006
732 PRODUCT DISPENSING ERROR 12 0.0006
733 CONTUSION 53 0.0005
734 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
735 METASTASES TO BONE 9 0.0005
736 GASTROENTERITIS 8 0.0005
737 EXPOSURE DURING PREGNANCY 34 0.0005
738 RHEUMATOID ARTHRITIS 62 0.0005
739 ROTATOR CUFF SYNDROME 7 0.0005
740 PHOTOSENSITIVITY REACTION 9 0.0005
741 RESPIRATORY ARREST 15 0.0005
742 RASH MACULAR 19 0.0005
743 ANGIOEDEMA 24 0.0005
744 ABDOMINAL PAIN 126 0.0005
745 HEADACHE 338 0.0005
746 DEEP VEIN THROMBOSIS 35 0.0005
747 WOUND 15 0.0005
748 INFLUENZA LIKE ILLNESS 44 0.0005
749 BEDRIDDEN 7 0.0005
750 TOOTH LOSS 11 0.0005
751 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
752 CIRCULATORY COLLAPSE 9 0.0005
753 BRADYCARDIA 28 0.0005
754 ABDOMINAL DISTENSION 55 0.0005
755 EYE HAEMORRHAGE 7 0.0005
756 MIGRAINE 50 0.0005
757 DRUG INEFFECTIVE 690 0.0005
758 HALLUCINATION, VISUAL 11 0.0005
759 LOWER LIMB FRACTURE 10 0.0005
760 JAUNDICE 14 0.0005
761 ANXIETY 148 0.0005
762 URTICARIA 87 0.0005
763 DYSPEPSIA 51 0.0005
764 LYMPHOMA 8 0.0005
765 MUSCULOSKELETAL CHEST PAIN 8 0.0005
766 EATING DISORDER 11 0.0005
767 DISEASE PROGRESSION 61 0.0005
768 SPEECH DISORDER 27 0.0005
769 STOMATITIS 31 0.0005
770 FAECES DISCOLOURED 11 0.0005
771 CONVULSION 29 0.0005
772 HERPES ZOSTER 29 0.0005
773 ARTHROPATHY 28 0.0005
774 RHABDOMYOLYSIS 21 0.0005
775 SKIN ULCER 13 0.0005
776 CYSTITIS 16 0.0005
777 FATIGUE 389 0.0005
778 CYTOKINE RELEASE SYNDROME 10 0.0005
779 HIP FRACTURE 16 0.0005
780 APHASIA 15 0.0005
781 ARTHRITIS 39 0.0005
782 OSTEOARTHRITIS 21 0.0005
783 ANAEMIA 94 0.0005
784 OEDEMA PERIPHERAL 60 0.0005
785 EMOTIONAL DISTRESS 59 0.0005
786 MULTIPLE FRACTURES 8 0.0005
787 PRODUCT PREPARATION ERROR 10 0.0005
788 AGRANULOCYTOSIS 9 0.0005
789 FREQUENT BOWEL MOVEMENTS 13 0.0005
790 HEPATIC CIRRHOSIS 9 0.0005
791 BONE DENSITY DECREASED 15 0.0005
792 MUSCLE TWITCHING 11 0.0005
793 DIABETES MELLITUS 36 0.0005
794 SLEEP APNOEA SYNDROME 9 0.0005
795 BLOOD PRESSURE INCREASED 72 0.0005
796 INFUSION RELATED REACTION 31 0.0005
797 GLAUCOMA 9 0.0005
798 BLOOD PRESSURE DECREASED 31 0.0005
799 DEPRESSION 106 0.0005
800 HEPATIC FAILURE 14 0.0005
801 EAR PAIN 9 0.0005
802 NAUSEA 366 0.0005
803 ABDOMINAL PAIN UPPER 95 0.0005
804 RASH PRURITIC 25 0.0005
805 CONFUSIONAL STATE 74 0.0005
806 ERYTHEMA 94 0.0005
807 ASTHENIA 171 0.0005
808 RED BLOOD CELL COUNT DECREASED 13 0.0005
809 PERIPHERAL SWELLING 70 0.0005
810 DEPRESSED MOOD 24 0.0005
811 MENTAL IMPAIRMENT 11 0.0005
812 HYPERTENSION 96 0.0005
813 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
814 HOT FLUSH 34 0.0005
815 SKIN EXFOLIATION 38 0.0004
816 SWOLLEN TONGUE 14 0.0004
817 THERAPEUTIC RESPONSE DECREASED 27 0.0004
818 ARRHYTHMIA 21 0.0004
819 ULCER 7 0.0004
820 C-REACTIVE PROTEIN INCREASED 16 0.0004
821 PAIN 269 0.0004
822 SKIN DISCOLOURATION 20 0.0004
823 DERMATITIS 9 0.0004
824 MIDDLE INSOMNIA 8 0.0004
825 OSTEONECROSIS 14 0.0004
826 WEIGHT INCREASED 95 0.0004
827 ARTHRALGIA 176 0.0004
828 PLATELET COUNT DECREASED 45 0.0004
829 EMOTIONAL DISORDER 13 0.0004
830 BLOOD URINE PRESENT 8 0.0004
831 FEELING JITTERY 8 0.0004
832 DRY SKIN 56 0.0004
833 INCREASED APPETITE 8 0.0004
834 BLOOD PRESSURE FLUCTUATION 10 0.0004
835 MYELOSUPPRESSION 15 0.0004
836 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
837 DRUG-INDUCED LIVER INJURY 13 0.0004
838 PANIC ATTACK 15 0.0004
839 HAEMORRHAGE 43 0.0004
840 DIZZINESS 205 0.0004
841 DYSPHAGIA 39 0.0004
842 RESTLESSNESS 15 0.0004
843 TOOTH DISORDER 9 0.0004
844 NIGHTMARE 14 0.0004
845 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
846 ORAL PAIN 9 0.0004
847 RASH PAPULAR 9 0.0004
848 PRODUCT AVAILABILITY ISSUE 9 0.0004
849 DISCOMFORT 24 0.0004
850 FLUID RETENTION 20 0.0004
851 NEUTROPHIL COUNT DECREASED 16 0.0004
852 BODY TEMPERATURE INCREASED 8 0.0004
853 GOUT 7 0.0004
854 FEMUR FRACTURE 12 0.0004
855 TOOTHACHE 7 0.0004
856 THROMBOSIS 31 0.0004
857 SWELLING 36 0.0004
858 AGITATION 28 0.0004
859 PAIN IN EXTREMITY 112 0.0004
860 FALL 126 0.0004
861 ADVERSE DRUG REACTION 34 0.0004
862 DISORIENTATION 15 0.0004
863 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
864 COMA 18 0.0004
865 PRODUCT STORAGE ERROR 33 0.0004
866 CARDIAC FAILURE 30 0.0004
867 PSYCHOTIC DISORDER 11 0.0004
868 DYSARTHRIA 14 0.0004
869 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
870 LIVER INJURY 9 0.0004
871 CARDIAC FAILURE CONGESTIVE 29 0.0004
872 SKIN FISSURES 7 0.0004
873 GAIT DISTURBANCE 68 0.0004
874 HEPATITIS 9 0.0004
875 PRURITUS 135 0.0004
876 FEELING ABNORMAL 84 0.0004
877 ABORTION SPONTANEOUS 14 0.0003
878 HEAD INJURY 11 0.0003
879 FULL BLOOD COUNT DECREASED 7 0.0003
880 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
881 MUSCULAR WEAKNESS 39 0.0003
882 PERITONITIS 7 0.0003
883 ALOPECIA 66 0.0003
884 FLATULENCE 19 0.0003
885 INTERSTITIAL LUNG DISEASE 16 0.0003
886 CRYING 12 0.0003
887 ABNORMAL BEHAVIOUR 13 0.0003
888 IRRITABLE BOWEL SYNDROME 7 0.0003
889 POOR QUALITY SLEEP 7 0.0003
890 ECZEMA 17 0.0003
891 DIVERTICULITIS 9 0.0003
892 PRODUCT PRESCRIBING ISSUE 7 0.0003
893 MELAENA 7 0.0003
894 GLOSSODYNIA 7 0.0003
895 POLLAKIURIA 13 0.0003
896 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 56 0.0003
897 SYNCOPE 31 0.0003
898 DYSGEUSIA 23 0.0003
899 HYPOGLYCAEMIA 15 0.0003
900 NEEDLE ISSUE 9 0.0003
901 TREMOR 51 0.0003
902 HALLUCINATION 23 0.0003
903 MUSCLE SPASMS 56 0.0003
904 JOINT STIFFNESS 8 0.0003
905 NO ADVERSE EVENT 55 0.0003
906 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
907 IRRITABILITY 18 0.0003
908 DYSURIA 11 0.0003
909 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
910 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
911 FLUSHING 30 0.0003
912 PRODUCT PRESCRIBING ERROR 7 0.0003
913 AMNESIA 19 0.0003
914 GASTRIC DISORDER 10 0.0003
915 LIMB DISCOMFORT 9 0.0003
916 CEREBROVASCULAR ACCIDENT 49 0.0003
917 INSOMNIA 77 0.0003
918 HYPOTHYROIDISM 9 0.0003
919 ABDOMINAL DISCOMFORT 47 0.0003
920 HYPERHIDROSIS 36 0.0003
921 CEREBRAL HAEMORRHAGE 10 0.0003
922 SOMNOLENCE 56 0.0003
923 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
924 GASTRIC CANCER 7 0.0003
925 INTENTIONAL PRODUCT MISUSE 24 0.0003
926 DYSSTASIA 8 0.0003
927 HYPOAESTHESIA 41 0.0003
928 HAEMATOCHEZIA 15 0.0003
929 ACUTE MYOCARDIAL INFARCTION 8 0.0003
930 DRY MOUTH 22 0.0003
931 BLOOD GLUCOSE DECREASED 13 0.0003
932 URINARY INCONTINENCE 8 0.0003
933 SKIN DISORDER 9 0.0003
934 GAIT INABILITY 9 0.0003
935 CARDIAC DISORDER 25 0.0003
936 PARAESTHESIA 41 0.0003
937 DISTURBANCE IN ATTENTION 14 0.0003
938 MOOD SWINGS 8 0.0003
939 MOVEMENT DISORDER 8 0.0002
940 MEMORY IMPAIRMENT 34 0.0002
941 UNDERDOSE 18 0.0002
942 DYSKINESIA 10 0.0002
943 ANGINA PECTORIS 7 0.0002
944 URINARY RETENTION 8 0.0002
945 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
946 INJECTION SITE SWELLING 18 0.0002
947 CORONARY ARTERY DISEASE 7 0.0002
948 PLASMA CELL MYELOMA 9 0.0002
949 DEVICE DISLOCATION 10 0.0002
950 MYALGIA 39 0.0002
951 DERMATITIS ATOPIC 12 0.0002
952 MOBILITY DECREASED 16 0.0002
953 EXTRA DOSE ADMINISTERED 9 0.0002
954 LOSS OF CONSCIOUSNESS 28 0.0002
955 BURNING SENSATION 15 0.0002
956 TYPE 2 DIABETES MELLITUS 7 0.0002
957 PALPITATIONS 24 0.0002
958 AGGRESSION 10 0.0002
959 DRUG DOSE OMISSION 33 0.0002
960 ACNE 15 0.0002
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
962 COGNITIVE DISORDER 9 0.0002
963 ROAD TRAFFIC ACCIDENT 8 0.0002
964 PRODUCT SUBSTITUTION ISSUE 11 0.0002
965 INCORRECT DOSE ADMINISTERED 43 0.0002
966 BLOOD GLUCOSE INCREASED 35 0.0002
967 DEVICE LEAKAGE 8 0.0002
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
969 NEOPLASM MALIGNANT 12 0.0002
970 FEELING HOT 11 0.0002
971 ANGER 6 0.0002
972 PROSTATE CANCER 14 0.0002
973 ADVERSE EVENT 16 0.0002
974 OVERDOSE 37 0.0002
975 BONE PAIN 10 0.0002
976 INJECTION SITE ERYTHEMA 20 0.0002
977 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
978 SUICIDAL IDEATION 14 0.0002
979 BLOOD CHOLESTEROL INCREASED 7 0.0002
980 DEVICE ISSUE 13 0.0001
981 MYOCARDIAL INFARCTION 25 0.0001
982 NERVOUSNESS 7 0.0001
983 PRODUCT QUALITY ISSUE 18 0.0001
984 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
985 INJECTION SITE PRURITUS 8 0.0001
986 DEVICE MALFUNCTION 8 0.0001
987 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
988 BREAST CANCER 10 0.0001
989 INJECTION SITE PAIN 31 0.0001
990 INJECTION SITE BRUISING 7 0.0001
991 PSORIASIS 9 0.0001
992 DRUG DEPENDENCE 11 0.0001